BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• Business

  Moleculin Reports Second Quarter 2022 Financial Results and Provides Programs Update

  Moleculin Biotech, Inc. today reported its financial results for the quarter ended June 30, 2022.

  August 15, 2022

   · 

  12 min read
• Deals

  Athersys, Inc. Announces $12 Million Registered Direct Offering

  Athersys, Inc. (Nasdaq: ATHX) today announced that it has entered into a definitive agreement with a single healthcare-focused U.S. institutional investor for the purchase and sale of 48,000,000 shares of the Company’s common stock.

  August 15, 2022

   · 

  3 min read
• Business

  Personalis in Partnership with BC Cancer to Assess Clinical and Economic Benefits of ctDNA for Colorectal and Pancreatic Cancers

  Personalis, Inc. has announced a collaboration with BC Cancer to deploy a personalized liquid biopsy-based research use only (RUO) assay for a study of patients with colorectal and pancreatic cancers.

  August 15, 2022

   · 

  5 min read
• Accelus Announces First Surgeries Using FlareHawk® TiHawk11™ Interbody Fusion System

  Accelus, a privately held medical technology company focused on accelerating the adoption of minimally invasive surgery (MIS) as the standard of care in spine, today announced the first spinal surgeries with the FlareHawk® TiHawk11™ Interbody Fusion System (TiHawk11).

  August 15, 2022

   · 

  3 min read
• Biotech Beach

  Immunis Publishes Research Study Showing Reversal of Aged Muscle Deficits

  Immunis Inc., announced the peer-reviewed publication in GeroScience of research conducted by Professor Micah Drummond at the University of Utah investigating the efficacy of Immunis’ immunomodulatory secretome product on aged skeletal muscle.

  August 15, 2022

   · 

  2 min read
• Microbiome Therapeutics Market Size, Trends, Growth | Report 2022-2030

  According to Precedence Research, the global microbiome therapeutics market size was estimated at around USD 84.3 million in 2021 and it is projected to hit around USD 973.86 million by 2030, growing at a CAGR of 31.24% from 2022 to 2030

  August 15, 2022

   · 

  6 min read
• Business

  Catalyst Biosciences Reports Second Quarter 2022 Operating & Financial Results

  Catalyst Biosciences, Inc. (NASDAQ: CBIO) (the “Company” or “we”) today announced its operating and financial results for the second quarter ended June 30, 2022.

  August 15, 2022

   · 

  8 min read
• Business

  Acer Therapeutics Reports Q2 2022 Financial Results and Provides Corporate Update

  Acer Therapeutics Inc. (Nasdaq: ACER), today reported financial results for the second quarter ended June 30, 2022, and provided a corporate update.

  August 15, 2022

   · 

  11 min read